Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Metronidazole
Sanofi
P01AB01
Metronidazole
400mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05011100; GTIN: 5000283652342
PAG 2 Avance bobina PAG 1 150 x 315 mm 838141 LC 149 Dirección de Lectura Dirección de Lectura PACKAGE LEAFLET: INFORMATION FOR THE USER FLAGYL TM 400MG TABLETS Metronidazole Is this leaflet hard to see or read? Phone 0800 035 2525 for help Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have further questions, please ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the leaflet. See section 4. What is in this leaflet: 1. What Flagyl is and what it is used for 2. What you need to know before you take Flagyl 3. How to take Flagyl 4. Possible side effects 5. How to store Flagyl 6. Contents of the pack and other information 1. WHAT FLAGYL IS AND WHAT IT IS USED FOR The name of this medicine is Flagyl 400mg Tablets (called Flagyl in this leaflet). Flagyl contains a medicine called metronidazole. This belongs to a group of medicines called antibiotics. It works by killing bacteria and parasites that cause infections in your body. It can be used to: • Treat infections of the blood, brain, lung, bones, genital tract, pelvic area, stomach and intestines • Treat gum ulcers and other dental infections • Treat infected leg ulcers and pressure sores • Prevent infections after surgery If you need any further information on your illness, speak to your doctor. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FLAGYL Do not take Flagyl if: X You are allergic (hypersensitive) to metronidazole, nitroimidazoles (e.g. tinidazole) or any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue. Do not take Flag Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Flagyl 400mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 400 mg metronidazole. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Flagyl tablets 400 mg: White to off-white, biconvex, capsule shaped, film coated tablets impressed ‘FLAGYL 400’ on one face, plain reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Flagyl is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. Flagyl is active against a wide range of pathogenic micro-organisms notably species of _Bacteroides_, _Fusobacteria_, _Clostridia_, _Eubacteria_, anaerobic cocci and _Gardnerella vaginalis_. It is also active against _Trichomonas_, _Entamoeba histolytica_, _Giardia lamblia_ and _Balantidium coli_. Flagyl is indicated in adults and children for the following indications: 1. The prevention of post-operative infections due to anaerobic bacteria, particularly species of _Bacteroides_ and anaerobic streptococci. 2. The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post-operative wound infections from which pathogenic anaerobes have been isolated. 3. Urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. Bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or Gardnerella vaginitis). 5. All forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. Giardiasis. 7. Acute ulcerative gingivitis. 8. Anaerobically-infected leg ulcers and pressure sores. 9. Acute dental infections (e.g. acute pericoronitis and acute apical infections). Considerations should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ _ 1. Prophylaxis against anaerobic infection: Chief Read the complete document